| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Escherichia coli (HEGP 402) |
- |
- |
2 － >256 |
Amoxicillin (Novamox, Amoxil)  |
1305 |
| Escherichia coli (HEGP 402) |
- |
- |
>2000 － ? |
Retama raetam (Butanol extract) |
1305 |
| Escherichia coli (HEGP 402) |
- |
- |
>2000 － ? |
Retama raetam (Ethyl acetate extract) |
1305 |
| Escherichia coli (HEGP 402) |
- |
- |
>2000 － ? |
Retama raetam (Methanol extract) |
1305 |
| Escherichia coli (HMS-1 + cefdinir-susceptible) |
- |
- |
0.25 － ? |
Cefdinir (Omnicef, Cefdiel) |
267 |
| Escherichia coli (HMS-1 + cefdinir-susceptible) |
- |
- |
0.25 － ? |
Cefixime (Suprax) |
267 |
| Escherichia coli (HN10318 + ESBL) |
- |
- |
2 － ? |
A-thanatin |
1089 |
| Escherichia coli (HN10318 + ESBL) |
- |
- |
16 － ? |
Levofloxacin (Levaquin, Quixin) |
1089 |
| Escherichia coli (HN10318 + ESBL) |
- |
- |
≤25 － ? |
Imipenem |
1089 |
| Escherichia coli (HN10318 + ESBL) |
- |
- |
32 － ? |
Ampicillin (Omnipen) |
1089 |
| Escherichia coli (HN10318 + ESBL) |
- |
- |
32 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1089 |
| Escherichia coli (HN10318 + ESBL) |
- |
- |
64 － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1089 |
| Escherichia coli (HN10318 + ESBL) |
- |
- |
>256 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1089 |
| Escherichia coli (HN10322) |
- |
- |
2 － ? |
A-thanatin |
1089 |
| Escherichia coli (HN10322) |
- |
- |
16 － ? |
Levofloxacin (Levaquin, Quixin) |
1089 |
| Escherichia coli (HN10322) |
- |
- |
≤25 － ? |
Imipenem |
1089 |
| Escherichia coli (HN10322) |
- |
- |
32 － ? |
Ampicillin (Omnipen) |
1089 |
| Escherichia coli (HN10322) |
- |
- |
32 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1089 |
| Escherichia coli (HN10322) |
- |
- |
64 － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1089 |
| Escherichia coli (HN10322) |
- |
- |
>256 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1089 |
| Escherichia coli (HN10349) |
- |
- |
0.5 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1089 |
| Escherichia coli (HN10349) |
- |
- |
1 － ? |
Levofloxacin (Levaquin, Quixin) |
1089 |
| Escherichia coli (HN10349) |
- |
- |
2 － ? |
A-thanatin |
1089 |
| Escherichia coli (HN10349) |
- |
- |
2 － ? |
Imipenem |
1089 |
| Escherichia coli (HN10349) |
- |
- |
>256 － ? |
Ampicillin (Omnipen) |
1089 |
| Escherichia coli (HN10349) |
- |
- |
>256 － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1089 |
| Escherichia coli (HN10349) |
- |
- |
>256 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1089 |
| Escherichia coli (HN10500) |
- |
- |
0.25 － ? |
Imipenem |
1089 |